A Case Series of Chronic Spontaneous Urticaria After COVID-19 Vaccination.

IF 4.1 2区医学 Q2 ALLERGY

Allergy, Asthma & Immunology Research Pub Date : 2023-09-01 Epub Date: 2023-01-26 DOI:10.4168/aair.2023.15.5.695

Jeong-Hee Choi, Soo Jie Chung

引用次数: 0

Abstract

Coronavirus disease 2019 (COVID-19) vaccines play an important role in overcoming the global COVID-19 pandemic. Various immediate or delayed types of cutaneous adverse reactions, such as local site reactions, urticaria, mobilliform rashes, and delayed large local reactions, have been noted after COVID-19 vaccination, which are usually treatable with time.1,2 Chronic spontaneous urticaria (CSU) is defined by recurrent hives lasting > 6 weeks.3 Some patients have developed CSU after COVID-19 vaccination.4-6 Here, we report 12 patients with CSU after COVID-19 vaccination in Korea. We describe the clinical characteristics, treatment, and prognosis of these patients.

Abstract Image

查看原文本刊更多论文

新冠肺炎疫苗接种后慢性自发性荨麻疹病例系列。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Allergy, Asthma & Immunology Research ALLERGY-IMMUNOLOGY

CiteScore

6.10

自引率

6.80%

发文量

审稿时长

>12 weeks

期刊介绍： The journal features cutting-edge original research, brief communications, and state-of-the-art reviews in the specialties of allergy, asthma, and immunology, including clinical and experimental studies and instructive case reports. Contemporary reviews summarize information on topics for researchers and physicians in the fields of allergy and immunology. As of January 2017, AAIR do not accept case reports. However, if it is a clinically important case, authors can submit it in the form of letter to the Editor. Editorials and letters to the Editor explore controversial issues and encourage further discussion among physicians dealing with allergy, immunology, pediatric respirology, and related medical fields. AAIR also features topics in practice and management and recent advances in equipment and techniques for clinicians concerned with clinical manifestations of allergies and pediatric respiratory diseases.